162 related articles for article (PubMed ID: 30534571)
1. Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility.
Qian C; Guo H; Chen X; Shi A; Li S; Wang X; Pan J; Fang C
J Diabetes Res; 2018; 2018():1614683. PubMed ID: 30534571
[TBL] [Abstract][Full Text] [Related]
2. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
Tan D; Sheng L; Yi QH
Cancer Biomark; 2018 Feb; 21(2):287-297. PubMed ID: 29171986
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
[TBL] [Abstract][Full Text] [Related]
4. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
[TBL] [Abstract][Full Text] [Related]
5. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
6. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
[TBL] [Abstract][Full Text] [Related]
7. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
Nomizo T; Ozasa H; Tsuji T; Funazo T; Yasuda Y; Yoshida H; Yagi Y; Sakamori Y; Nagai H; Hirai T; Kim YH
Sci Rep; 2017 Mar; 7():45124. PubMed ID: 28332580
[TBL] [Abstract][Full Text] [Related]
9. Association of a
Venugopal G; O'Regan NL; Babu S; Schumann RR; Srikantam A; Merle R; Hartmann S; Steinfelder S
Am J Trop Med Hyg; 2019 Feb; 100(2):344-350. PubMed ID: 30594267
[TBL] [Abstract][Full Text] [Related]
10. Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.
Han R; Gong X; Zhu Y; Liu X; Xia Y; Huang Y; Zhang M; Zhang Y; La X; Ding J
Biomed Res Int; 2021; 2021():9596358. PubMed ID: 33521133
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile.
Pizarro C; García-Díaz DF; Codner E; Salas-Pérez F; Carrasco E; Pérez-Bravo F
Diabetes Metab Res Rev; 2014 Nov; 30(8):761-6. PubMed ID: 24816853
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
13. Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.
Yang J; Meng L; Yang Y; Gao H; Jiang H
Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):230-248. PubMed ID: 37688463
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
[TBL] [Abstract][Full Text] [Related]
15. GLIS3 rs7020673 and rs10758593 polymorphisms interact in the susceptibility for type 1 diabetes mellitus.
Duarte GCK; Assmann TS; Dieter C; de Souza BM; Crispim D
Acta Diabetol; 2017 Sep; 54(9):813-821. PubMed ID: 28597135
[TBL] [Abstract][Full Text] [Related]
16. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects.
Zhang W; Song Y; Zhang X
Med Sci Monit; 2021 May; 27():e932146. PubMed ID: 34024901
[TBL] [Abstract][Full Text] [Related]
18. Potential role of immune cell genetic variants associated with tumor microenvironment response in laryngeal squamous cell carcinoma (LSCC) in terms of clinicopathological features.
Horozoglu C; Sonmez D; Demirkol S; Hakan MT; Kaleler I; Hepokur C; Verim A; Yaylim I
Pathol Res Pract; 2021 Dec; 228():153665. PubMed ID: 34717150
[TBL] [Abstract][Full Text] [Related]
19. PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients.
Fichna M; Zurawek M; Januszkiewicz-Lewandowska D; Fichna P; Nowak J
Int J Immunogenet; 2010 Oct; 37(5):367-72. PubMed ID: 20518841
[TBL] [Abstract][Full Text] [Related]
20. Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.
Chen YB; Mu CY; Chen C; Huang JA
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e1-6. PubMed ID: 23167931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
